Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601830-26-000019
Filing Date
2026-02-19
Accepted
2026-02-19 19:30:39
Documents
1
Period of Report
2026-02-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1771547436.html 4  
1 FORM 4 wk-form4_1771547436.xml 4 3315
  Complete submission text file 0001601830-26-000019.txt   4851
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address
Khan Najat (Reporting) CIK: 0002020969 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40323 | Film No.: 26656171